Literature DB >> 3121604

Primary structure of beta-galactoside alpha 2,6-sialyltransferase. Conversion of membrane-bound enzyme to soluble forms by cleavage of the NH2-terminal signal anchor.

J Weinstein1, E U Lee, K McEntee, P H Lai, J C Paulson.   

Abstract

This report describes the primary structure of a rat liver beta-galactoside alpha 2,6-sialyltransferase (EC 2.4.99.1), a Golgi apparatus enzyme involved in the terminal sialylation of N-linked carbohydrate groups of glycoproteins. The complete amino acid sequence was deduced from the nucleotide sequence of cDNA clones of the enzyme. The primary structure suggests that the topology of the enzyme in the Golgi apparatus consists of a short NH2-terminal cytoplasmic domain, a 17-residue hydrophobic sequence which serves as the membrane anchor and signal sequence, and a large lumenal, catalytic domain. NH2-terminal sequence analysis of a truncated form of the enzyme, obtained by purification from tissue homogenates, reveals that it is missing a 63-residue NH2-terminal peptide which includes the membrane binding domain. These and supporting results show that soluble forms of the sialyltransferase can be generated by proteolytic cleavage between the NH2-terminal signal-anchor and the catalytic domain.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3121604

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  100 in total

Review 1.  Synthesis of oligosaccharides by bacterial enzymes.

Authors:  K F Johnson
Journal:  Glycoconj J       Date:  1999-02       Impact factor: 2.916

2.  Alzheimer's beta-secretase, beta-site amyloid precursor protein-cleaving enzyme, is responsible for cleavage secretion of a Golgi-resident sialyltransferase.

Authors:  S Kitazume; Y Tachida; R Oka; K Shirotani; T C Saido; Y Hashimoto
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-06       Impact factor: 11.205

3.  Improved glycosylation of a foreign protein by Tn-5B1-4 cells engineered to express mammalian glycosyltransferases.

Authors:  K Breitbach; D L Jarvis
Journal:  Biotechnol Bioeng       Date:  2001-08-05       Impact factor: 4.530

Review 4.  Sialyltransferases in cancer.

Authors:  F Dall'Olio; M Chiricolo
Journal:  Glycoconj J       Date:  2001 Nov-Dec       Impact factor: 2.916

Review 5.  Involvement of proteases in glycosyltransferase secretion: Alzheimer's beta-secretase-dependent cleavage and a following processing by an aminopeptidase.

Authors:  Shinobu Kitazume; Minoru Suzuki; Takaomi C Saido; Yasuhiro Hashimoto
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

6.  Genetic engineering of α2,6-sialyltransferase in recombinant CHO cells and its effects on the sialylation of recombinant interferon-γ.

Authors:  L Monaco; A Marc; A Eon-Duval; G Acerbis; G Distefano; D Lamotte; J M Engasser; M Soria; N Jenkins
Journal:  Cytotechnology       Date:  1996-01       Impact factor: 2.058

Review 7.  Functional aspects of glycoprotein N-linked oligosaccharide processing by human tumours.

Authors:  C S Foster
Journal:  Br J Cancer Suppl       Date:  1990-07

8.  Molecular cloning, sequence, and expression of a human GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase cDNA that can form the H blood group antigen.

Authors:  R D Larsen; L K Ernst; R P Nair; J B Lowe
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

9.  Peptide-specific transfer of N-acetylgalactosamine to O-linked glycans by the glycosyltransferases β1,4-N-acetylgalactosaminyl transferase 3 (β4GalNAc-T3) and β4GalNAc-T4.

Authors:  Dorothy Fiete; Mary Beranek; Jacques U Baenziger
Journal:  J Biol Chem       Date:  2012-06-21       Impact factor: 5.157

10.  Isolation of a cDNA encoding a murine UDPgalactose:beta-D-galactosyl- 1,4-N-acetyl-D-glucosaminide alpha-1,3-galactosyltransferase: expression cloning by gene transfer.

Authors:  R D Larsen; V P Rajan; M M Ruff; J Kukowska-Latallo; R D Cummings; J B Lowe
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.